Provider
P21-22 Medical Drug Management Update – Infliximab Prior Authorization and Preferred Product Expansion to Include Unbranded Infliximab
Program effective Date: Apr 01, 2022
Program effective Date: Apr 01, 2022
Program effective Date: Apr 01, 2022
Program effective Date: Apr 01, 2022
Program effective Date: Apr 01, 2022
Program effective Date: Apr 01, 2022
Program effective Date: Mar 23, 2022
Program effective Date: Mar 09, 2022
Program effective Date: Mar 09, 2022
Program effective Date: Mar 09, 2022
Program effective Date: Mar 09, 2022